Covina, CA, United States of America

Peishing Hu


Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 2010-2012

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Peishing Hu: Innovator in Cancer Immunotherapy

Introduction

Peishing Hu is a notable inventor based in Covina, California, recognized for his contributions to cancer immunotherapy. With a total of three patents, he has made significant strides in developing methods to combat cancer through innovative therapeutic approaches.

Latest Patents

Peishing Hu's latest patents focus on combination cancer immunotherapy with co-stimulatory molecules. These patents provide methods for reducing tumor size or inhibiting the growth of cancer cells in individuals. The techniques involve administering an effective amount of a soluble form of a co-stimulatory molecule derived from antigen-presenting cells. Additionally, the methods aim to reduce the activity of immunoregulatory T cells, either by removing them ex vivo or depleting or inactivating them in vivo. The patents also include cancer therapeutic compositions that comprise a soluble form of a co-stimulatory molecule and an antibody specific for an intracellular antigen.

Career Highlights

Peishing Hu is affiliated with the University of Southern California, where he continues to advance his research in cancer therapies. His work has garnered attention for its potential to improve treatment outcomes for cancer patients.

Collaborations

Peishing Hu collaborates with various professionals in the field, including his coworker Alan L Epstein, to enhance the effectiveness of his research and innovations.

Conclusion

Peishing Hu's innovative work in cancer immunotherapy exemplifies the impact of scientific research on healthcare. His patents and ongoing contributions are paving the way for new therapeutic strategies in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…